title: ODM-201 is safe and active in metastatic castration-resistant prostate cancer.
abstract: The next-generation AR inhibitor ODM-201 is tolerable and induces PSA responses in metastatic CRPC.
mesh_terms: D059002:Androgen Receptor Antagonists / Q000494:pharmacology*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000401:mortality*; D011720:Pyrazoles / Q000494:pharmacology*
chemical_list: D059002:Androgen Receptor Antagonists; D011720:Pyrazoles; D017430:Prostate-Specific Antigen